THEIA was awarded the BIST Ignite Grant in March, 2017. The news release can be found here.
THEIA combines the expertise and experience of BIST centers in microscopy, graphene and medical instrumentation to develop a new generation of retinal prostheses based on MEA (multi-electrode array) graphene devices. The high photosensitivity of the material will allow great improvements to the vision of people treated with this type of technology, now very limited by the small number of electrodes that can be implanted in one of the current retinal chips. Graphene also offers advantages such as flexibility, biocompatibility, and transparency. The project, in which the Barraquer Ophthalmological Center is participating, aims to have a proof of concept ready for this new chip in three years.
Multidisciplinarity within THEIA
The experiments in this project will receive input from all partners of the project. A multidisciplinary approach will be implemented through sharing specific tasks (ICN2 will be the main contributor to the implementation of the graphene based MEA, IFAE will be mainly involved in the implementation of the electronic controller for the MEA, and ICFO will be in charge of the microscopy experiments) as well as sharing know-how through a series of presentations and talks.
Follow this page for updates about the project.